More than six million Americans have Alzheimer’s disease and related dementias, a number that is projected to double by 2060.

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

"This research highlights the potential for aerobic exercise to serve as a cornerstone in preventive strategies for Alzheimer ...

There’s no polite way to discuss this, but so blow the winds of change. The term “fart walks” is trending right now, though ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

The geroscience hypothesis focuses on extending the healthy lifespan by targeting aging mechanisms. Recent advances in ...

Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...